2025/09/01 by Mina Popovic, Catello Scarica, Susana M. Chuva de Sousa Lopes +1 · 1 voice
Biochemistry, Genetics and Molecular Biology · Medicine · #Organ Donation and Transplantation #Renal and related cancers #Reproductive Health and Technologies
paper · pdf · doi:10.1242/dev.205133
openalex publication_date 2025/09/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/27
In an era of expanding reproductive possibilities, the human embryo has come to represent both immense potential and profound constraint. Advances in medically assisted reproduction (MAR) have led to the cryopreservation of hundreds of thousands of embryos each year, yet many remain unused and are ultimately discarded. Meanwhile, studies aimed at understanding infertility, early human development and preventing miscarriage continue to face significant barriers, with only a small fraction of embryos ever donated to research. This disconnect, shaped by regulatory ambiguity, raises a deeper question: is it more ethical to discard an embryo than to learn from it? This Perspective outlines the biological inefficiencies of human reproduction and the clinical imperative to improve MAR outcomes. We then examine the global patchwork of embryo research regulation by comparing national approaches. Drawing on examples from both clinical and research practice, we argue that permissiveness alone does not guarantee scientific progress, just as restriction does not ensure ethical integrity. A meaningful global conversation on embryo research must move beyond the binary of permissiveness versus prohibition, and toward frameworks that support responsible, transparent, and ethically grounded innovation.